Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Vinod K. Ahirrao"'
Publikováno v:
Journal of Analytical Science and Technology, Vol 11, Iss 1, Pp 1-9 (2020)
Abstract Alalevonadifloxacin mesylate (ALA), pro-drug of levonadifloxacin is a new antibiotic approved in India to treat infections caused by Gram-positive bacteria. Alkyl mesylates (AMs) are known genotoxic impurities (GTI’s) formed in drug substa
Externí odkaz:
https://doaj.org/article/3eb5d9728342463e962ab0b796486c24
Autor:
Rajiv A. Jadhav, Vinod K. Ahirrao, Rushikesh H. Patil, Kiran B. More, Anil R. Tile, Vipul P. Rane, Pravin S. Sonawane, Ravindra D. Yeole
Publikováno v:
Analytical Chemistry Letters. 12:409-418
Autor:
Vipul P. Rane, Rushikesh H. Patil, Kiran R. Patil, Amin R. Pathan, Sukantakumar Naik, Vinod K. Ahirrao, Rajiv A. Jadhav, Ravindra D. Yeole
Publikováno v:
Chromatographia. 85:155-165
Autor:
Vinod K. Ahirrao, Rushikesh H. Patil, Vipul P. Rane, Kiran R. Patil, Ravindra D. Yeole, Amin R. Pathan
Publikováno v:
Chromatographia. 84:1121-1130
WCK 4086 is new antibacterial drug being developed to treat infections caused by Gram positive bacteria. This study describes development of mass spectrometry (MS) compatible reversed phase liquid chromatographic method for separation, identification
Publikováno v:
Journal of Chromatographic Science. 58:951-960
Alalevonadifloxacin (ALA, formerly described as WCK 2349) is a novel antibacterial drug developed to treat infections caused by Gram-positive bacteria. The current study was aimed to identify and quantify impurities in ALA. Mass spectrometry (MS) com
Autor:
Vipul P. Rane, Rajiv A. Jadhav, Amin R. Pathan, Ravindra D. Yeole, Kiran R. Patil, Vinod K. Ahirrao
Publikováno v:
Chromatographia. 83:1095-1105
A mass spectrometer compatible, reverse-phase high-performance liquid chromatography method capable to resolve twenty-six impurities and degradation products (DPs) in Ertapenem (ERT) has been developed. Eight dimer impurities (m/z 951) and two dehydr
Publikováno v:
Journal of Analytical Science and Technology, Vol 11, Iss 1, Pp 1-9 (2020)
Alalevonadifloxacin mesylate (ALA), pro-drug of levonadifloxacin is a new antibiotic approved in India to treat infections caused by Gram-positive bacteria. Alkyl mesylates (AMs) are known genotoxic impurities (GTI’s) formed in drug substances isol
Publikováno v:
Chromatographia. 83:423-437
Zidebactam (ZID) is a novel drug in clinical development; it potentiates the antibacterial activity of β-lactam antibiotics. Two reversed phase liquid chromatographic (RP-LC) methods were developed for ZID; a mass spectrometer (MS) compatible method
Autor:
Kiran R. Patil, Vipul P. Rane, Vijay S. Bhamare, Vinod K. Ahirrao, Ravindra D. Yeole, Rajiv A. Jadhav, Dharamvir S. Yadav
Publikováno v:
Chromatographia. 83:219-228
Zidebactam (ZID), a novel β-lactam enhancer drug being developed to treat infections caused by Gram-negative bacteria, currently is in phase III clinical development. Two ionic impurities observed in liquid chromatography with charged aerosol detect
Autor:
Arjun B Jadhav, Vipul P. Rane, Ravindra D. Yeole, Kiran R. Patil, Vinod K. Ahirrao, Kiran B More
Publikováno v:
Journal of Chromatographic Science. 57:815-820
Ethyl nipecotate enantiomers are widely used as chiral building blocks in the synthesis of drug substances. An efficient and economic chiral high-performance liquid chromatographic method for determination of enantiomeric purity of ethyl nipecotate i